Sowell Financial Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,424
Closed -$456K 3414
2020
Q4
$280K Sell
2,424
-309
-11% -$34.6K 0.01% 723
2020
Q3
$266K Sell
2,733
-250
-8% -$28.8K 0.01% 652
2020
Q2
$366K Sell
2,983
-367
-11% -$41.6K 0.02% 544
2020
Q1
$293K Sell
3,350
-46
-1% -$4.87K 0.02% 553
2019
Q4
$355K Buy
3,396
+418
+14% +$46.9K 0.03% 548
2019
Q3
$343K Buy
+2,978
New +$452K 0.03% 501
2019
Q1
$259K Buy
+1,539
New +$229K 0.03% 482
2018
Q4
Sell
-1,179
Closed -$204K 550
2018
Q3
$204K Buy
+1,179
New +$170K 0.03% 330

Other funds holding GWPH

Sowell Financial Services's GWPH Position: Q1 2021 in Review

Sowell Financial Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,424 shares — an estimated $456K sold.

Sowell Financial Services first reported a position in GWPH in Q3 2018 and held it in 8 quarters. The position peaked at $366K in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Sowell Financial Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,424 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $456K.
  • Sowell Financial Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 8 quarters.
  • Sowell Financial Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $366K in Q2 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.